![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 19, 16379-16390, May 11, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the For the widely distributed P2Y
receptors for nucleotides, the transductional and functional responses
downstream of their coupling to G proteins are poorly characterized.
Here we describe apoptotic induction and the associated differential
stimulation of mitogen-activated protein (MAP) kinase family members by
the human P2Y1 receptor. The potent P2Y1
receptor agonist, 2-methylthio-ADP (2-MeSADP), stimulated the
extracellular-signal regulated kinases (ERK1/2) (EC50 ~5
nM) as well as several, but not all isoforms detected, of
the stress-activated protein kinase (SAPK) family. Phospho-isoforms of
p38 were unaffected. The induced kinase activity was blocked by the
P2Y1 receptor-selective antagonist,
adenosine-2'-phosphate-5'-phosphate, but unaffected by pertussis toxin.
In addition, the endogenous ligand ADP, and significantly also
2-MeSATP, induced concentration-dependent phosphorylation
changes in the same MAP kinase family members. The sustained activation
of ERK1/2 was associated with Elk-1 phosphorylation that was
abolished by the MEK1 inhibitor, PD 98059. However, the concomitant
transient activation of the SAPKs was not sufficient to induce c-Jun or
ATF-2 phosphorylation. The transient phase of the ERK activity was
partially inhibited either by the phosphatidylinositol 3-kinase
inhibitor, LY 294002, or the PKC inhibitor, Gö 6976. In addition,
the Src inhibitor, PP1, or expression of dominant negative Ras also
attenuated the transient phase of ERK phosphorylation. In contrast,
inhibition of Ras or Src had no effect on the sustained ERK
activity, which was critically dependent on phosphatidylinositol 3-kinase. The transient SAPK activity was suppressed by expression of a
dominant negative form of MKK4. Furthermore, this kinase-deficient mutant inhibited 2-MeSADP-induced caspase-3 stimulation and the associated decrease in cell number. In conclusion, adenosine di- and
triphosphate stimulation of the human P2Y1 receptor can
transiently activate the Ras-ERK cascade via the cooperative effects of
phosphatidylinositol 3-kinase, Src and PKC. The sustained ERK
stimulation, via a Ras-insensitive pathway, culminates in Elk-1
activation without inducing a proliferation effect. The transient SAPK
activity did not evoke transcription factor phosphorylation but was
required for the P2Y1 receptor-mediated apoptotic function.
Adenosine Nucleotides Acting at the Human P2Y1
Receptor Stimulate Mitogen-activated Protein Kinases and Induce
Apoptosis*
§,
,
,
, and
Glaxo Institute of Applied Pharmacology,
Department of Pharmacology, University of Cambridge,
Cambridge CB2 1QJ and the ¶ 7TM Receptor Systems Unit, Molecular
Pharmacology Department, Glaxo Wellcome Medicines Research Centre,
Gunnels Wood Road, Stevenage, Hertfordshire
2G1 2NY, United Kingdom
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
R. C. Y. Choi, J. Simon, K. W. K. Tsim, and E. A. Barnard Constitutive and Agonist-induced Dimerizations of the P2Y1 Receptor: RELATIONSHIP TO INTERNALIZATION AND SCAFFOLDING J. Biol. Chem., April 18, 2008; 283(16): 11050 - 11063. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shen and P. E. DiCorleto ADP Stimulates Human Endothelial Cell Migration via P2Y1 Nucleotide Receptor-Mediated Mitogen-Activated Protein Kinase Pathways Circ. Res., February 29, 2008; 102(4): 448 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hohenstein, S. Renk, K. Lang, C. Daniel, M. Freund, C. Leon, K. U. Amann, C. Gachet, and C. P.M. Hugo P2Y1 Gene Deficiency Protects from Renal Disease Progression and Capillary Rarefaction during Passive Crescentic Glomerulonephritis J. Am. Soc. Nephrol., February 1, 2007; 18(2): 494 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al. International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy Pharmacol. Rev., September 1, 2006; 58(3): 281 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Geary, H. Akinbi, T. Korfhagen, J.-E. Fabre, R. Boucher, and W. Rice Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L890 - L895. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Fam, M. Paquet, A. M. Castleberry, H. Oller, C. J. Lee, S. F. Traynelis, Y. Smith, C. C. Yun, and R. A. Hall P2Y1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2 PNAS, May 31, 2005; 102(22): 8042 - 8047. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Coutinho-Silva, L. Stahl, K.-K. Cheung, N. E. de Campos, C. de Oliveira Souza, D. M. Ojcius, and G. Burnstock P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G1024 - G1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Shah, J. A. Olivares-Reyes, and K. J. Catt The Protein Kinase C Inhibitor Go6976 [12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] Potentiates Agonist-Induced Mitogen-Activated Protein Kinase Activation through Tyrosine Phosphorylation of the Epidermal Growth Factor Receptor Mol. Pharmacol., January 1, 2005; 67(1): 184 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. K. Tung, R. C. Y. Choi, N. L. Siow, J. X. S. Jiang, K. K. Y. Ling, J. Simon, E. A. Barnard, and K. W. K. Tsim P2Y2 Receptor Activation Regulates the Expression of Acetylcholinesterase and Acetylcholine Receptor Genes at Vertebrate Neuromuscular Junctions Mol. Pharmacol., October 1, 2004; 66(4): 794 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Dranoff, M. Ogawa, E. A. Kruglov, M. D. A. Gaca, J. Sevigny, S. C. Robson, and R. G. Wells Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells Am J Physiol Gastrointest Liver Physiol, August 1, 2004; 287(2): G417 - G424. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Y. Choi, N. L. Siow, A. W. M. Cheng, K. K. Y. Ling, E. K. K. Tung, J. Simon, E. A. Barnard, and K. W. K. Tsim ATP Acts via P2Y1 Receptors to Stimulate Acetylcholinesterase and Acetylcholine Receptor Expression: Transduction and Transcription Control J. Neurosci., June 1, 2003; 23(11): 4445 - 4456. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Junankar, A. Karjalainen, and K. Kirk The Role of P2Y1 Purinergic Receptors and Cytosolic Ca2+ in Hypotonically Activated Osmolyte Efflux from a Rat Hepatoma Cell Line J. Biol. Chem., October 18, 2002; 277(43): 40324 - 40334. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Simon, A. K. Filippov, S. Goransson, Y. H. Wong, C. Frelin, A. D. Michel, D. A. Brown, and E. A. Barnard Characterization and Channel Coupling of the P2Y12 Nucleotide Receptor of Brain Capillary Endothelial Cells J. Biol. Chem., August 23, 2002; 277(35): 31390 - 31400. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Burnstock Purinergic Signaling and Vascular Cell Proliferation and Death Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 364 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Y. Choi, M. L. S. Man, K. K. Y. Ling, N. Y. Ip, J. Simon, E. A. Barnard, and K. W. K. Tsim Expression of the P2Y1 Nucleotide Receptor in Chick Muscle: Its Functional Role in the Regulation of Acetylcholinesterase and Acetylcholine Receptor J. Neurosci., December 1, 2001; 21(23): 9224 - 9234. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |